nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—ADRA1A—hypertension	0.119	0.376	CbGaD
Zuclopenthixol—ADRA2A—hypertension	0.0839	0.266	CbGaD
Zuclopenthixol—DRD2—hypertension	0.0637	0.202	CbGaD
Zuclopenthixol—Chlorpromazine—Diltiazem—hypertension	0.0557	1	CrCrCtD
Zuclopenthixol—HTR2A—hypertension	0.0492	0.156	CbGaD
Zuclopenthixol—DRD5—Fenoldopam—hypertension	0.0441	0.122	CbGbCtD
Zuclopenthixol—DRD1—Fenoldopam—hypertension	0.0225	0.0621	CbGbCtD
Zuclopenthixol—ADRA2A—Methyldopa—hypertension	0.0206	0.0567	CbGbCtD
Zuclopenthixol—ADRA2A—Guanabenz—hypertension	0.0188	0.0519	CbGbCtD
Zuclopenthixol—ADRA2A—Guanfacine—hypertension	0.0175	0.0482	CbGbCtD
Zuclopenthixol—ADRA1A—Terazosin—hypertension	0.0158	0.0435	CbGbCtD
Zuclopenthixol—ADRA2A—Fenoldopam—hypertension	0.0149	0.041	CbGbCtD
Zuclopenthixol—ADRA1A—Fenoldopam—hypertension	0.0143	0.0393	CbGbCtD
Zuclopenthixol—ADRA2A—Doxazosin—hypertension	0.0137	0.0378	CbGbCtD
Zuclopenthixol—DRD2—Fenoldopam—hypertension	0.0137	0.0378	CbGbCtD
Zuclopenthixol—ADRA1A—Doxazosin—hypertension	0.0132	0.0363	CbGbCtD
Zuclopenthixol—ADRA2A—Prazosin—hypertension	0.0113	0.0311	CbGbCtD
Zuclopenthixol—ADRA1A—Prazosin—hypertension	0.0108	0.0298	CbGbCtD
Zuclopenthixol—ADRA2A—Carvedilol—hypertension	0.00973	0.0268	CbGbCtD
Zuclopenthixol—ADRA1A—Nicardipine—hypertension	0.00933	0.0257	CbGbCtD
Zuclopenthixol—ADRA1A—Carvedilol—hypertension	0.00933	0.0257	CbGbCtD
Zuclopenthixol—ADRA2A—Clonidine—hypertension	0.00854	0.0235	CbGbCtD
Zuclopenthixol—ADRA1A—Clonidine—hypertension	0.00819	0.0226	CbGbCtD
Zuclopenthixol—CYP2D6—Nebivolol—hypertension	0.00684	0.0189	CbGbCtD
Zuclopenthixol—CYP2D6—Labetalol—hypertension	0.00684	0.0189	CbGbCtD
Zuclopenthixol—CYP2D6—Acebutolol—hypertension	0.00626	0.0172	CbGbCtD
Zuclopenthixol—CYP2D6—Pindolol—hypertension	0.00582	0.016	CbGbCtD
Zuclopenthixol—CYP2D6—Metoprolol—hypertension	0.00582	0.016	CbGbCtD
Zuclopenthixol—CYP2D6—Betaxolol—hypertension	0.00518	0.0143	CbGbCtD
Zuclopenthixol—CYP2D6—Doxazosin—hypertension	0.00456	0.0126	CbGbCtD
Zuclopenthixol—CYP2D6—Diltiazem—hypertension	0.00441	0.0122	CbGbCtD
Zuclopenthixol—CYP2D6—Bepridil—hypertension	0.00393	0.0108	CbGbCtD
Zuclopenthixol—CYP2D6—Irbesartan—hypertension	0.00359	0.00991	CbGbCtD
Zuclopenthixol—CYP2D6—Amlodipine—hypertension	0.00352	0.00971	CbGbCtD
Zuclopenthixol—CYP2D6—Felodipine—hypertension	0.0034	0.00937	CbGbCtD
Zuclopenthixol—CYP2D6—Timolol—hypertension	0.00334	0.00921	CbGbCtD
Zuclopenthixol—CYP2D6—Nifedipine—hypertension	0.00329	0.00906	CbGbCtD
Zuclopenthixol—CYP2D6—Carvedilol—hypertension	0.00324	0.00892	CbGbCtD
Zuclopenthixol—CYP2D6—Nicardipine—hypertension	0.00324	0.00892	CbGbCtD
Zuclopenthixol—CYP2D6—Propranolol—hypertension	0.00298	0.00821	CbGbCtD
Zuclopenthixol—CYP2D6—Captopril—hypertension	0.00294	0.00811	CbGbCtD
Zuclopenthixol—CYP2D6—Clonidine—hypertension	0.00284	0.00783	CbGbCtD
Zuclopenthixol—CYP2D6—Atorvastatin—hypertension	0.00253	0.00698	CbGbCtD
Zuclopenthixol—CYP2D6—Verapamil—hypertension	0.00204	0.00563	CbGbCtD
Zuclopenthixol—HTR2A—arteriole—hypertension	0.00191	0.0953	CbGeAlD
Zuclopenthixol—HTR2A—locus ceruleus—hypertension	0.00154	0.0768	CbGeAlD
Zuclopenthixol—HTR2A—pulmonary artery—hypertension	0.00125	0.0625	CbGeAlD
Zuclopenthixol—HTR2A—sympathetic nervous system—hypertension	0.00122	0.0607	CbGeAlD
Zuclopenthixol—HTR2A—vagus nerve—hypertension	0.00118	0.0588	CbGeAlD
Zuclopenthixol—HTR2A—vein—hypertension	0.00114	0.0568	CbGeAlD
Zuclopenthixol—HTR2A—autonomic nervous system—hypertension	0.00082	0.0408	CbGeAlD
Zuclopenthixol—HTR2A—hindlimb—hypertension	0.000758	0.0378	CbGeAlD
Zuclopenthixol—HTR2A—urine—hypertension	0.000668	0.0333	CbGeAlD
Zuclopenthixol—CYP2D6—urine—hypertension	0.000609	0.0303	CbGeAlD
Zuclopenthixol—DRD1—brainstem—hypertension	0.000508	0.0253	CbGeAlD
Zuclopenthixol—HTR2A—artery—hypertension	0.000465	0.0232	CbGeAlD
Zuclopenthixol—HTR2A—endothelium—hypertension	0.000393	0.0196	CbGeAlD
Zuclopenthixol—DRD5—endocrine gland—hypertension	0.000372	0.0185	CbGeAlD
Zuclopenthixol—HTR2A—blood vessel—hypertension	0.000362	0.018	CbGeAlD
Zuclopenthixol—HTR6—central nervous system—hypertension	0.000344	0.0172	CbGeAlD
Zuclopenthixol—DRD5—central nervous system—hypertension	0.000335	0.0167	CbGeAlD
Zuclopenthixol—ADRA1A—brainstem—hypertension	0.000306	0.0153	CbGeAlD
Zuclopenthixol—DRD2—brainstem—hypertension	0.0003	0.0149	CbGeAlD
Zuclopenthixol—ADRA1A—heart—hypertension	0.000265	0.0132	CbGeAlD
Zuclopenthixol—DRD1—central nervous system—hypertension	0.000256	0.0128	CbGeAlD
Zuclopenthixol—ADRA1A—cardiovascular system—hypertension	0.00025	0.0124	CbGeAlD
Zuclopenthixol—HRH1—smooth muscle tissue—hypertension	0.000203	0.0101	CbGeAlD
Zuclopenthixol—ADRA2A—heart—hypertension	0.000201	0.01	CbGeAlD
Zuclopenthixol—HRH1—decidua—hypertension	0.000199	0.00993	CbGeAlD
Zuclopenthixol—HTR2A—brainstem—hypertension	0.000198	0.00986	CbGeAlD
Zuclopenthixol—ADRA1A—adrenal gland—hypertension	0.000198	0.00985	CbGeAlD
Zuclopenthixol—ADRA2A—decidua—hypertension	0.000196	0.00975	CbGeAlD
Zuclopenthixol—ADRA2A—cortex of kidney—hypertension	0.000181	0.00902	CbGeAlD
Zuclopenthixol—CYP2D6—brainstem—hypertension	0.00018	0.00898	CbGeAlD
Zuclopenthixol—ADRA2A—cardiac atrium—hypertension	0.000172	0.00858	CbGeAlD
Zuclopenthixol—ADRA1A—endocrine gland—hypertension	0.000171	0.00854	CbGeAlD
Zuclopenthixol—HTR2A—heart—hypertension	0.000171	0.00853	CbGeAlD
Zuclopenthixol—HTR2A—smooth muscle tissue—hypertension	0.00017	0.00846	CbGeAlD
Zuclopenthixol—DRD2—endocrine gland—hypertension	0.000168	0.00837	CbGeAlD
Zuclopenthixol—ADRA2A—medulla oblongata—hypertension	0.000162	0.00809	CbGeAlD
Zuclopenthixol—HTR2A—cardiovascular system—hypertension	0.000162	0.00805	CbGeAlD
Zuclopenthixol—HTR2A—kidney—hypertension	0.000158	0.00787	CbGeAlD
Zuclopenthixol—ADRA1A—central nervous system—hypertension	0.000154	0.00769	CbGeAlD
Zuclopenthixol—HRH1—adrenal gland—hypertension	0.000153	0.00762	CbGeAlD
Zuclopenthixol—DRD2—central nervous system—hypertension	0.000151	0.00754	CbGeAlD
Zuclopenthixol—ADRA2A—adrenal gland—hypertension	0.00015	0.00749	CbGeAlD
Zuclopenthixol—CYP2D6—kidney—hypertension	0.000144	0.00717	CbGeAlD
Zuclopenthixol—HTR2A—medulla oblongata—hypertension	0.000138	0.00688	CbGeAlD
Zuclopenthixol—HRH1—endocrine gland—hypertension	0.000133	0.00661	CbGeAlD
Zuclopenthixol—ADRA2A—endocrine gland—hypertension	0.00013	0.00649	CbGeAlD
Zuclopenthixol—HTR2A—adrenal gland—hypertension	0.000128	0.00636	CbGeAlD
Zuclopenthixol—HRH1—central nervous system—hypertension	0.00012	0.00596	CbGeAlD
Zuclopenthixol—ADRA2A—central nervous system—hypertension	0.000117	0.00585	CbGeAlD
Zuclopenthixol—HTR2A—endocrine gland—hypertension	0.000111	0.00552	CbGeAlD
Zuclopenthixol—Fluphenazine—CALM2—hypertension	0.000101	0.0267	CrCbGaD
Zuclopenthixol—CYP2D6—endocrine gland—hypertension	0.000101	0.00503	CbGeAlD
Zuclopenthixol—HTR2A—central nervous system—hypertension	9.99e-05	0.00497	CbGeAlD
Zuclopenthixol—Flupentixol—ADRA1A—hypertension	9.94e-05	0.0263	CrCbGaD
Zuclopenthixol—CYP2D6—central nervous system—hypertension	9.1e-05	0.00453	CbGeAlD
Zuclopenthixol—Trifluoperazine—CALM2—hypertension	8.08e-05	0.0213	CrCbGaD
Zuclopenthixol—Perphenazine—CALM2—hypertension	7.99e-05	0.0211	CrCbGaD
Zuclopenthixol—Nefazodone—SLC6A2—hypertension	7.89e-05	0.0208	CrCbGaD
Zuclopenthixol—Trazodone—HTR2B—hypertension	6.85e-05	0.0181	CrCbGaD
Zuclopenthixol—Fluphenazine—CALM1—hypertension	6.51e-05	0.0172	CrCbGaD
Zuclopenthixol—Chlorpromazine—CALM2—hypertension	6.34e-05	0.0168	CrCbGaD
Zuclopenthixol—Amoxapine—SLC6A2—hypertension	6.01e-05	0.0159	CrCbGaD
Zuclopenthixol—Amoxapine—HTR2B—hypertension	5.65e-05	0.0149	CrCbGaD
Zuclopenthixol—Nefazodone—ADRA1A—hypertension	5.56e-05	0.0147	CrCbGaD
Zuclopenthixol—Propericiazine—ADRA2A—hypertension	5.52e-05	0.0146	CrCbGaD
Zuclopenthixol—Loxapine—ADRA2B—hypertension	5.34e-05	0.0141	CrCbGaD
Zuclopenthixol—Flupentixol—DRD2—hypertension	5.34e-05	0.0141	CrCbGaD
Zuclopenthixol—Quetiapine—ADRA2B—hypertension	5.22e-05	0.0138	CrCbGaD
Zuclopenthixol—Trifluoperazine—CALM1—hypertension	5.21e-05	0.0138	CrCbGaD
Zuclopenthixol—Domperidone—DRD3—hypertension	5.19e-05	0.0137	CrCbGaD
Zuclopenthixol—Perphenazine—CALM1—hypertension	5.15e-05	0.0136	CrCbGaD
Zuclopenthixol—Trazodone—ADRA1A—hypertension	5.14e-05	0.0136	CrCbGaD
Zuclopenthixol—Trifluoperazine—XDH—hypertension	5.09e-05	0.0134	CrCbGaD
Zuclopenthixol—Chlorprothixene—HTR2B—hypertension	5.05e-05	0.0134	CrCbGaD
Zuclopenthixol—Clozapine—HRH3—hypertension	5.05e-05	0.0133	CrCbGaD
Zuclopenthixol—Domperidone—CYP3A5—hypertension	5.03e-05	0.0133	CrCbGaD
Zuclopenthixol—Thioproperazine—ADRA1A—hypertension	4.9e-05	0.0129	CrCbGaD
Zuclopenthixol—Acetophenazine—DRD2—hypertension	4.74e-05	0.0125	CrCbGaD
Zuclopenthixol—Loxapine—SLC6A2—hypertension	4.69e-05	0.0124	CrCbGaD
Zuclopenthixol—Clozapine—ADRA2B—hypertension	4.49e-05	0.0119	CrCbGaD
Zuclopenthixol—Amoxapine—ADRA1A—hypertension	4.23e-05	0.0112	CrCbGaD
Zuclopenthixol—Nefazodone—CYP3A5—hypertension	4.18e-05	0.011	CrCbGaD
Zuclopenthixol—Flupentixol—HTR2A—hypertension	4.13e-05	0.0109	CrCbGaD
Zuclopenthixol—Chlorpromazine—CALM1—hypertension	4.08e-05	0.0108	CrCbGaD
Zuclopenthixol—Nefazodone—SLC6A3—hypertension	4.01e-05	0.0106	CrCbGaD
Zuclopenthixol—Nefazodone—ADRA2A—hypertension	3.93e-05	0.0104	CrCbGaD
Zuclopenthixol—Trazodone—CYP3A5—hypertension	3.87e-05	0.0102	CrCbGaD
Zuclopenthixol—Perphenazine—CYP2C18—hypertension	3.76e-05	0.00993	CrCbGaD
Zuclopenthixol—Trazodone—ADRA2A—hypertension	3.64e-05	0.00962	CrCbGaD
Zuclopenthixol—Domperidone—DRD2—hypertension	3.59e-05	0.0095	CrCbGaD
Zuclopenthixol—Thioridazine—ADRA1A—hypertension	3.59e-05	0.00948	CrCbGaD
Zuclopenthixol—Prochlorperazine—DRD3—hypertension	3.57e-05	0.00944	CrCbGaD
Zuclopenthixol—Amoxapine—HTR7—hypertension	3.5e-05	0.00924	CrCbGaD
Zuclopenthixol—Chlorpromazine—HTR2B—hypertension	3.48e-05	0.0092	CrCbGaD
Zuclopenthixol—Thiothixene—ADRA2A—hypertension	3.41e-05	0.00901	CrCbGaD
Zuclopenthixol—Amoxapine—HTR1B—hypertension	3.39e-05	0.00895	CrCbGaD
Zuclopenthixol—Trifluoperazine—ADRA1A—hypertension	3.33e-05	0.0088	CrCbGaD
Zuclopenthixol—Loxapine—ADRA1A—hypertension	3.31e-05	0.00874	CrCbGaD
Zuclopenthixol—Amoxapine—DRD3—hypertension	3.29e-05	0.00869	CrCbGaD
Zuclopenthixol—Fluphenazine—DRD3—hypertension	3.23e-05	0.00854	CrCbGaD
Zuclopenthixol—Quetiapine—ADRA1A—hypertension	3.23e-05	0.00853	CrCbGaD
Zuclopenthixol—Amoxapine—SLC6A3—hypertension	3.06e-05	0.00808	CrCbGaD
Zuclopenthixol—Nefazodone—SLC6A4—hypertension	3e-05	0.00793	CrCbGaD
Zuclopenthixol—Amoxapine—ADRA2A—hypertension	3e-05	0.00792	CrCbGaD
Zuclopenthixol—Thioridazine—HTR7—hypertension	2.96e-05	0.00783	CrCbGaD
Zuclopenthixol—Fluphenazine—ADRA2A—hypertension	2.95e-05	0.00779	CrCbGaD
Zuclopenthixol—Chlorprothixene—DRD3—hypertension	2.94e-05	0.00778	CrCbGaD
Zuclopenthixol—Clozapine—ADRA1A—hypertension	2.78e-05	0.00734	CrCbGaD
Zuclopenthixol—Trazodone—SLC6A4—hypertension	2.78e-05	0.00734	CrCbGaD
Zuclopenthixol—Loxapine—HTR7—hypertension	2.73e-05	0.00722	CrCbGaD
Zuclopenthixol—Perphenazine—HTR7—hypertension	2.72e-05	0.00718	CrCbGaD
Zuclopenthixol—Quetiapine—HTR7—hypertension	2.66e-05	0.00704	CrCbGaD
Zuclopenthixol—Loxapine—HTR1B—hypertension	2.64e-05	0.00699	CrCbGaD
Zuclopenthixol—Thioproperazine—DRD2—hypertension	2.63e-05	0.00695	CrCbGaD
Zuclopenthixol—Chlorpromazine—ADRA1A—hypertension	2.61e-05	0.0069	CrCbGaD
Zuclopenthixol—Thiothixene—DRD2—hypertension	2.59e-05	0.00684	CrCbGaD
Zuclopenthixol—Pipotiazine—DRD2—hypertension	2.59e-05	0.00684	CrCbGaD
Zuclopenthixol—Quetiapine—HTR1B—hypertension	2.58e-05	0.00682	CrCbGaD
Zuclopenthixol—Loxapine—DRD3—hypertension	2.57e-05	0.00678	CrCbGaD
Zuclopenthixol—Thioridazine—ADRA2A—hypertension	2.54e-05	0.00671	CrCbGaD
Zuclopenthixol—Quetiapine—DRD3—hypertension	2.51e-05	0.00662	CrCbGaD
Zuclopenthixol—Prochlorperazine—DRD2—hypertension	2.47e-05	0.00653	CrCbGaD
Zuclopenthixol—Quetiapine—CYP3A5—hypertension	2.43e-05	0.00642	CrCbGaD
Zuclopenthixol—Loxapine—SLC6A3—hypertension	2.39e-05	0.00631	CrCbGaD
Zuclopenthixol—Loxapine—ADRA2A—hypertension	2.34e-05	0.00619	CrCbGaD
Zuclopenthixol—Loxapine—ADRB1—hypertension	2.34e-05	0.00618	CrCbGaD
Zuclopenthixol—Perphenazine—ADRA2A—hypertension	2.33e-05	0.00616	CrCbGaD
Zuclopenthixol—Nefazodone—HTR2A—hypertension	2.31e-05	0.00609	CrCbGaD
Zuclopenthixol—Clozapine—HTR7—hypertension	2.29e-05	0.00606	CrCbGaD
Zuclopenthixol—Amoxapine—SLC6A4—hypertension	2.29e-05	0.00604	CrCbGaD
Zuclopenthixol—Quetiapine—ADRA2A—hypertension	2.29e-05	0.00604	CrCbGaD
Zuclopenthixol—Amoxapine—DRD2—hypertension	2.27e-05	0.00601	CrCbGaD
Zuclopenthixol—Fluphenazine—DRD2—hypertension	2.24e-05	0.00591	CrCbGaD
Zuclopenthixol—Clozapine—HTR1B—hypertension	2.22e-05	0.00587	CrCbGaD
Zuclopenthixol—Chlorpromazine—HTR7—hypertension	2.16e-05	0.0057	CrCbGaD
Zuclopenthixol—Clozapine—DRD3—hypertension	2.16e-05	0.0057	CrCbGaD
Zuclopenthixol—Trazodone—HTR2A—hypertension	2.13e-05	0.00564	CrCbGaD
Zuclopenthixol—Chlorprothixene—DRD2—hypertension	2.04e-05	0.00538	CrCbGaD
Zuclopenthixol—Thioproperazine—HTR2A—hypertension	2.03e-05	0.00537	CrCbGaD
Zuclopenthixol—Chlorpromazine—DRD3—hypertension	2.03e-05	0.00536	CrCbGaD
Zuclopenthixol—Thiothixene—HTR2A—hypertension	2e-05	0.00528	CrCbGaD
Zuclopenthixol—Pipotiazine—HTR2A—hypertension	2e-05	0.00528	CrCbGaD
Zuclopenthixol—Clozapine—ADRA2A—hypertension	1.97e-05	0.0052	CrCbGaD
Zuclopenthixol—Thioridazine—DRD2—hypertension	1.93e-05	0.00509	CrCbGaD
Zuclopenthixol—Chlorpromazine—ADRA2A—hypertension	1.85e-05	0.00489	CrCbGaD
Zuclopenthixol—Trifluoperazine—DRD2—hypertension	1.79e-05	0.00472	CrCbGaD
Zuclopenthixol—Loxapine—SLC6A4—hypertension	1.79e-05	0.00472	CrCbGaD
Zuclopenthixol—Loxapine—DRD2—hypertension	1.78e-05	0.00469	CrCbGaD
Zuclopenthixol—Perphenazine—DRD2—hypertension	1.77e-05	0.00467	CrCbGaD
Zuclopenthixol—Amoxapine—HTR2A—hypertension	1.76e-05	0.00464	CrCbGaD
Zuclopenthixol—Quetiapine—DRD2—hypertension	1.73e-05	0.00458	CrCbGaD
Zuclopenthixol—Fluphenazine—HTR2A—hypertension	1.73e-05	0.00457	CrCbGaD
Zuclopenthixol—Vomiting—Verapamil—hypertension	1.69e-05	0.000109	CcSEcCtD
Zuclopenthixol—Shock—Ramipril—hypertension	1.69e-05	0.000109	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Enalapril—hypertension	1.69e-05	0.000109	CcSEcCtD
Zuclopenthixol—Abdominal pain—Perindopril—hypertension	1.69e-05	0.000109	CcSEcCtD
Zuclopenthixol—Body temperature increased—Perindopril—hypertension	1.69e-05	0.000109	CcSEcCtD
Zuclopenthixol—Palpitations—Lisinopril—hypertension	1.69e-05	0.000109	CcSEcCtD
Zuclopenthixol—Diarrhoea—Olmesartan—hypertension	1.69e-05	0.000109	CcSEcCtD
Zuclopenthixol—Headache—Eplerenone—hypertension	1.69e-05	0.000109	CcSEcCtD
Zuclopenthixol—Rash—Nifedipine—hypertension	1.68e-05	0.000108	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Ramipril—hypertension	1.68e-05	0.000108	CcSEcCtD
Zuclopenthixol—Dermatitis—Nifedipine—hypertension	1.68e-05	0.000108	CcSEcCtD
Zuclopenthixol—Body temperature increased—Irbesartan—hypertension	1.68e-05	0.000108	CcSEcCtD
Zuclopenthixol—Abdominal pain—Irbesartan—hypertension	1.68e-05	0.000108	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Ramipril—hypertension	1.68e-05	0.000108	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Timolol—hypertension	1.68e-05	0.000108	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Lisinopril—hypertension	1.68e-05	0.000108	CcSEcCtD
Zuclopenthixol—Rash—Verapamil—hypertension	1.68e-05	0.000108	CcSEcCtD
Zuclopenthixol—Tachycardia—Ramipril—hypertension	1.68e-05	0.000108	CcSEcCtD
Zuclopenthixol—Dermatitis—Verapamil—hypertension	1.67e-05	0.000108	CcSEcCtD
Zuclopenthixol—Headache—Nifedipine—hypertension	1.67e-05	0.000108	CcSEcCtD
Zuclopenthixol—Pruritus—Clonidine—hypertension	1.67e-05	0.000108	CcSEcCtD
Zuclopenthixol—Body temperature increased—Hydrochlorothiazide—hypertension	1.67e-05	0.000107	CcSEcCtD
Zuclopenthixol—Abdominal pain—Hydrochlorothiazide—hypertension	1.67e-05	0.000107	CcSEcCtD
Zuclopenthixol—Skin disorder—Ramipril—hypertension	1.67e-05	0.000107	CcSEcCtD
Zuclopenthixol—Headache—Verapamil—hypertension	1.67e-05	0.000107	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Telmisartan—hypertension	1.67e-05	0.000107	CcSEcCtD
Zuclopenthixol—Nausea—Indapamide—hypertension	1.66e-05	0.000107	CcSEcCtD
Zuclopenthixol—Nausea—Diltiazem—hypertension	1.66e-05	0.000107	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Ramipril—hypertension	1.66e-05	0.000107	CcSEcCtD
Zuclopenthixol—Asthenia—Trandolapril—hypertension	1.65e-05	0.000106	CcSEcCtD
Zuclopenthixol—Shock—Timolol—hypertension	1.65e-05	0.000106	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Losartan—hypertension	1.65e-05	0.000106	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Timolol—hypertension	1.65e-05	0.000106	CcSEcCtD
Zuclopenthixol—Nausea—Carvedilol—hypertension	1.65e-05	0.000106	CcSEcCtD
Zuclopenthixol—Asthenia—Enalapril—hypertension	1.64e-05	0.000106	CcSEcCtD
Zuclopenthixol—Body temperature increased—Furosemide—hypertension	1.64e-05	0.000106	CcSEcCtD
Zuclopenthixol—Abdominal pain—Furosemide—hypertension	1.64e-05	0.000106	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Losartan—hypertension	1.64e-05	0.000105	CcSEcCtD
Zuclopenthixol—Dizziness—Valsartan—hypertension	1.64e-05	0.000105	CcSEcCtD
Zuclopenthixol—Anorexia—Ramipril—hypertension	1.64e-05	0.000105	CcSEcCtD
Zuclopenthixol—Skin disorder—Timolol—hypertension	1.63e-05	0.000105	CcSEcCtD
Zuclopenthixol—Dizziness—Olmesartan—hypertension	1.63e-05	0.000105	CcSEcCtD
Zuclopenthixol—Pruritus—Trandolapril—hypertension	1.63e-05	0.000105	CcSEcCtD
Zuclopenthixol—Nausea—Doxazosin—hypertension	1.63e-05	0.000105	CcSEcCtD
Zuclopenthixol—Myalgia—Lisinopril—hypertension	1.62e-05	0.000105	CcSEcCtD
Zuclopenthixol—Body temperature increased—Betaxolol—hypertension	1.62e-05	0.000105	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Timolol—hypertension	1.62e-05	0.000105	CcSEcCtD
Zuclopenthixol—Asthenia—Telmisartan—hypertension	1.62e-05	0.000104	CcSEcCtD
Zuclopenthixol—Pruritus—Enalapril—hypertension	1.62e-05	0.000104	CcSEcCtD
Zuclopenthixol—Anxiety—Lisinopril—hypertension	1.62e-05	0.000104	CcSEcCtD
Zuclopenthixol—Diarrhoea—Clonidine—hypertension	1.61e-05	0.000104	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	1.61e-05	0.000104	CcSEcCtD
Zuclopenthixol—Nausea—Fosinopril—hypertension	1.61e-05	0.000104	CcSEcCtD
Zuclopenthixol—Discomfort—Lisinopril—hypertension	1.6e-05	0.000103	CcSEcCtD
Zuclopenthixol—Hypotension—Ramipril—hypertension	1.6e-05	0.000103	CcSEcCtD
Zuclopenthixol—Anorexia—Timolol—hypertension	1.6e-05	0.000103	CcSEcCtD
Zuclopenthixol—Pruritus—Telmisartan—hypertension	1.6e-05	0.000103	CcSEcCtD
Zuclopenthixol—Nausea—Eplerenone—hypertension	1.6e-05	0.000103	CcSEcCtD
Zuclopenthixol—Dry mouth—Lisinopril—hypertension	1.59e-05	0.000102	CcSEcCtD
Zuclopenthixol—Nausea—Nifedipine—hypertension	1.59e-05	0.000102	CcSEcCtD
Zuclopenthixol—Body temperature increased—Losartan—hypertension	1.58e-05	0.000102	CcSEcCtD
Zuclopenthixol—Abdominal pain—Losartan—hypertension	1.58e-05	0.000102	CcSEcCtD
Zuclopenthixol—Nausea—Verapamil—hypertension	1.58e-05	0.000102	CcSEcCtD
Zuclopenthixol—Asthenia—Captopril—hypertension	1.58e-05	0.000102	CcSEcCtD
Zuclopenthixol—Diarrhoea—Trandolapril—hypertension	1.57e-05	0.000101	CcSEcCtD
Zuclopenthixol—Vomiting—Valsartan—hypertension	1.57e-05	0.000101	CcSEcCtD
Zuclopenthixol—Chlorprothixene—HTR2A—hypertension	1.57e-05	0.00416	CrCbGaD
Zuclopenthixol—Diarrhoea—Enalapril—hypertension	1.57e-05	0.000101	CcSEcCtD
Zuclopenthixol—Hypotension—Timolol—hypertension	1.57e-05	0.000101	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Irbesartan—hypertension	1.57e-05	0.000101	CcSEcCtD
Zuclopenthixol—Vomiting—Olmesartan—hypertension	1.57e-05	0.000101	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Ramipril—hypertension	1.56e-05	0.000101	CcSEcCtD
Zuclopenthixol—Rash—Valsartan—hypertension	1.56e-05	0.000101	CcSEcCtD
Zuclopenthixol—Dizziness—Clonidine—hypertension	1.56e-05	0.000101	CcSEcCtD
Zuclopenthixol—Dermatitis—Valsartan—hypertension	1.56e-05	0.0001	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Lisinopril—hypertension	1.56e-05	0.0001	CcSEcCtD
Zuclopenthixol—Pruritus—Captopril—hypertension	1.56e-05	0.0001	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Hydrochlorothiazide—hypertension	1.55e-05	0.0001	CcSEcCtD
Zuclopenthixol—Rash—Olmesartan—hypertension	1.55e-05	0.0001	CcSEcCtD
Zuclopenthixol—Insomnia—Ramipril—hypertension	1.55e-05	0.0001	CcSEcCtD
Zuclopenthixol—Dermatitis—Olmesartan—hypertension	1.55e-05	0.0001	CcSEcCtD
Zuclopenthixol—Headache—Valsartan—hypertension	1.55e-05	9.99e-05	CcSEcCtD
Zuclopenthixol—Diarrhoea—Telmisartan—hypertension	1.55e-05	9.96e-05	CcSEcCtD
Zuclopenthixol—Headache—Olmesartan—hypertension	1.54e-05	9.94e-05	CcSEcCtD
Zuclopenthixol—Paraesthesia—Ramipril—hypertension	1.54e-05	9.93e-05	CcSEcCtD
Zuclopenthixol—Shock—Lisinopril—hypertension	1.53e-05	9.87e-05	CcSEcCtD
Zuclopenthixol—Asthenia—Perindopril—hypertension	1.53e-05	9.87e-05	CcSEcCtD
Zuclopenthixol—Dyspnoea—Ramipril—hypertension	1.53e-05	9.86e-05	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Timolol—hypertension	1.53e-05	9.85e-05	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Furosemide—hypertension	1.53e-05	9.85e-05	CcSEcCtD
Zuclopenthixol—Asthenia—Irbesartan—hypertension	1.53e-05	9.83e-05	CcSEcCtD
Zuclopenthixol—Somnolence—Ramipril—hypertension	1.53e-05	9.83e-05	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Lisinopril—hypertension	1.52e-05	9.82e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Trandolapril—hypertension	1.52e-05	9.8e-05	CcSEcCtD
Zuclopenthixol—Tachycardia—Lisinopril—hypertension	1.52e-05	9.79e-05	CcSEcCtD
Zuclopenthixol—Insomnia—Timolol—hypertension	1.52e-05	9.78e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Enalapril—hypertension	1.52e-05	9.76e-05	CcSEcCtD
Zuclopenthixol—Asthenia—Hydrochlorothiazide—hypertension	1.51e-05	9.75e-05	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Betaxolol—hypertension	1.51e-05	9.75e-05	CcSEcCtD
Zuclopenthixol—Skin disorder—Lisinopril—hypertension	1.51e-05	9.74e-05	CcSEcCtD
Zuclopenthixol—Dyspepsia—Ramipril—hypertension	1.51e-05	9.73e-05	CcSEcCtD
Zuclopenthixol—Pruritus—Perindopril—hypertension	1.51e-05	9.73e-05	CcSEcCtD
Zuclopenthixol—Paraesthesia—Timolol—hypertension	1.51e-05	9.71e-05	CcSEcCtD
Zuclopenthixol—Pruritus—Irbesartan—hypertension	1.5e-05	9.7e-05	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Lisinopril—hypertension	1.5e-05	9.7e-05	CcSEcCtD
Zuclopenthixol—Diarrhoea—Captopril—hypertension	1.5e-05	9.69e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Clonidine—hypertension	1.5e-05	9.66e-05	CcSEcCtD
Zuclopenthixol—Dyspnoea—Timolol—hypertension	1.5e-05	9.64e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Telmisartan—hypertension	1.49e-05	9.63e-05	CcSEcCtD
Zuclopenthixol—Pruritus—Hydrochlorothiazide—hypertension	1.49e-05	9.62e-05	CcSEcCtD
Zuclopenthixol—Decreased appetite—Ramipril—hypertension	1.49e-05	9.61e-05	CcSEcCtD
Zuclopenthixol—Somnolence—Timolol—hypertension	1.49e-05	9.61e-05	CcSEcCtD
Zuclopenthixol—Clozapine—DRD2—hypertension	1.49e-05	0.00394	CrCbGaD
Zuclopenthixol—Thioridazine—HTR2A—hypertension	1.49e-05	0.00393	CrCbGaD
Zuclopenthixol—Asthenia—Furosemide—hypertension	1.49e-05	9.59e-05	CcSEcCtD
Zuclopenthixol—Rash—Clonidine—hypertension	1.49e-05	9.58e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Clonidine—hypertension	1.49e-05	9.58e-05	CcSEcCtD
Zuclopenthixol—Anorexia—Lisinopril—hypertension	1.48e-05	9.56e-05	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Ramipril—hypertension	1.48e-05	9.55e-05	CcSEcCtD
Zuclopenthixol—Fatigue—Ramipril—hypertension	1.48e-05	9.53e-05	CcSEcCtD
Zuclopenthixol—Headache—Clonidine—hypertension	1.48e-05	9.52e-05	CcSEcCtD
Zuclopenthixol—Dyspepsia—Timolol—hypertension	1.48e-05	9.52e-05	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Losartan—hypertension	1.47e-05	9.5e-05	CcSEcCtD
Zuclopenthixol—Asthenia—Betaxolol—hypertension	1.47e-05	9.49e-05	CcSEcCtD
Zuclopenthixol—Nausea—Valsartan—hypertension	1.47e-05	9.47e-05	CcSEcCtD
Zuclopenthixol—Pruritus—Furosemide—hypertension	1.47e-05	9.46e-05	CcSEcCtD
Zuclopenthixol—Constipation—Ramipril—hypertension	1.47e-05	9.46e-05	CcSEcCtD
Zuclopenthixol—Nausea—Olmesartan—hypertension	1.46e-05	9.43e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Trandolapril—hypertension	1.46e-05	9.43e-05	CcSEcCtD
Zuclopenthixol—Diarrhoea—Perindopril—hypertension	1.46e-05	9.41e-05	CcSEcCtD
Zuclopenthixol—Decreased appetite—Timolol—hypertension	1.46e-05	9.4e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Enalapril—hypertension	1.46e-05	9.39e-05	CcSEcCtD
Zuclopenthixol—Diarrhoea—Irbesartan—hypertension	1.46e-05	9.38e-05	CcSEcCtD
Zuclopenthixol—Hypotension—Lisinopril—hypertension	1.45e-05	9.37e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Captopril—hypertension	1.45e-05	9.36e-05	CcSEcCtD
Zuclopenthixol—Pruritus—Betaxolol—hypertension	1.45e-05	9.36e-05	CcSEcCtD
Zuclopenthixol—Rash—Trandolapril—hypertension	1.45e-05	9.35e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Trandolapril—hypertension	1.45e-05	9.34e-05	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Timolol—hypertension	1.45e-05	9.33e-05	CcSEcCtD
Zuclopenthixol—Fatigue—Timolol—hypertension	1.45e-05	9.32e-05	CcSEcCtD
Zuclopenthixol—Rash—Enalapril—hypertension	1.45e-05	9.31e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Enalapril—hypertension	1.44e-05	9.3e-05	CcSEcCtD
Zuclopenthixol—Diarrhoea—Hydrochlorothiazide—hypertension	1.44e-05	9.3e-05	CcSEcCtD
Zuclopenthixol—Headache—Trandolapril—hypertension	1.44e-05	9.29e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Telmisartan—hypertension	1.44e-05	9.26e-05	CcSEcCtD
Zuclopenthixol—Asthenia—Losartan—hypertension	1.44e-05	9.25e-05	CcSEcCtD
Zuclopenthixol—Headache—Enalapril—hypertension	1.44e-05	9.25e-05	CcSEcCtD
Zuclopenthixol—Pain—Timolol—hypertension	1.43e-05	9.24e-05	CcSEcCtD
Zuclopenthixol—Rash—Telmisartan—hypertension	1.43e-05	9.18e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Telmisartan—hypertension	1.42e-05	9.17e-05	CcSEcCtD
Zuclopenthixol—Diarrhoea—Furosemide—hypertension	1.42e-05	9.15e-05	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Lisinopril—hypertension	1.42e-05	9.14e-05	CcSEcCtD
Zuclopenthixol—Pruritus—Losartan—hypertension	1.42e-05	9.12e-05	CcSEcCtD
Zuclopenthixol—Clozapine—CYP1A1—hypertension	1.42e-05	0.00374	CrCbGaD
Zuclopenthixol—Headache—Telmisartan—hypertension	1.42e-05	9.12e-05	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Ramipril—hypertension	1.41e-05	9.11e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Perindopril—hypertension	1.41e-05	9.09e-05	CcSEcCtD
Zuclopenthixol—Insomnia—Lisinopril—hypertension	1.41e-05	9.07e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Irbesartan—hypertension	1.41e-05	9.06e-05	CcSEcCtD
Zuclopenthixol—Diarrhoea—Betaxolol—hypertension	1.41e-05	9.05e-05	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Ramipril—hypertension	1.4e-05	9.04e-05	CcSEcCtD
Zuclopenthixol—Chlorpromazine—DRD2—hypertension	1.4e-05	0.00371	CrCbGaD
Zuclopenthixol—Nausea—Clonidine—hypertension	1.4e-05	9.03e-05	CcSEcCtD
Zuclopenthixol—Paraesthesia—Lisinopril—hypertension	1.4e-05	9.01e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Captopril—hypertension	1.4e-05	9e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Hydrochlorothiazide—hypertension	1.4e-05	8.99e-05	CcSEcCtD
Zuclopenthixol—Thioproperazine—ALB—hypertension	1.39e-05	0.00367	CrCbGaD
Zuclopenthixol—Dyspnoea—Lisinopril—hypertension	1.39e-05	8.94e-05	CcSEcCtD
Zuclopenthixol—Rash—Captopril—hypertension	1.39e-05	8.93e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Captopril—hypertension	1.38e-05	8.92e-05	CcSEcCtD
Zuclopenthixol—Somnolence—Lisinopril—hypertension	1.38e-05	8.92e-05	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Timolol—hypertension	1.38e-05	8.91e-05	CcSEcCtD
Zuclopenthixol—Trifluoperazine—HTR2A—hypertension	1.38e-05	0.00365	CrCbGaD
Zuclopenthixol—Headache—Captopril—hypertension	1.38e-05	8.87e-05	CcSEcCtD
Zuclopenthixol—Loxapine—HTR2A—hypertension	1.37e-05	0.00363	CrCbGaD
Zuclopenthixol—Gastrointestinal pain—Timolol—hypertension	1.37e-05	8.84e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Furosemide—hypertension	1.37e-05	8.84e-05	CcSEcCtD
Zuclopenthixol—Dyspepsia—Lisinopril—hypertension	1.37e-05	8.83e-05	CcSEcCtD
Zuclopenthixol—Diarrhoea—Losartan—hypertension	1.37e-05	8.82e-05	CcSEcCtD
Zuclopenthixol—Pipotiazine—ALB—hypertension	1.37e-05	0.00362	CrCbGaD
Zuclopenthixol—Thiothixene—ALB—hypertension	1.37e-05	0.00362	CrCbGaD
Zuclopenthixol—Nausea—Trandolapril—hypertension	1.37e-05	8.81e-05	CcSEcCtD
Zuclopenthixol—Perphenazine—HTR2A—hypertension	1.37e-05	0.00361	CrCbGaD
Zuclopenthixol—Nausea—Enalapril—hypertension	1.36e-05	8.77e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Betaxolol—hypertension	1.36e-05	8.75e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Perindopril—hypertension	1.36e-05	8.74e-05	CcSEcCtD
Zuclopenthixol—Body temperature increased—Ramipril—hypertension	1.36e-05	8.74e-05	CcSEcCtD
Zuclopenthixol—Abdominal pain—Ramipril—hypertension	1.36e-05	8.74e-05	CcSEcCtD
Zuclopenthixol—Decreased appetite—Lisinopril—hypertension	1.35e-05	8.72e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Irbesartan—hypertension	1.35e-05	8.71e-05	CcSEcCtD
Zuclopenthixol—Rash—Perindopril—hypertension	1.35e-05	8.67e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Perindopril—hypertension	1.34e-05	8.66e-05	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Lisinopril—hypertension	1.34e-05	8.66e-05	CcSEcCtD
Zuclopenthixol—Nausea—Telmisartan—hypertension	1.34e-05	8.65e-05	CcSEcCtD
Zuclopenthixol—Fatigue—Lisinopril—hypertension	1.34e-05	8.65e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Hydrochlorothiazide—hypertension	1.34e-05	8.64e-05	CcSEcCtD
Zuclopenthixol—Rash—Irbesartan—hypertension	1.34e-05	8.64e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Irbesartan—hypertension	1.34e-05	8.63e-05	CcSEcCtD
Zuclopenthixol—Quetiapine—HTR2A—hypertension	1.34e-05	0.00354	CrCbGaD
Zuclopenthixol—Headache—Perindopril—hypertension	1.34e-05	8.61e-05	CcSEcCtD
Zuclopenthixol—Headache—Irbesartan—hypertension	1.33e-05	8.59e-05	CcSEcCtD
Zuclopenthixol—Pain—Lisinopril—hypertension	1.33e-05	8.58e-05	CcSEcCtD
Zuclopenthixol—Constipation—Lisinopril—hypertension	1.33e-05	8.58e-05	CcSEcCtD
Zuclopenthixol—Rash—Hydrochlorothiazide—hypertension	1.33e-05	8.57e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Hydrochlorothiazide—hypertension	1.33e-05	8.56e-05	CcSEcCtD
Zuclopenthixol—Abdominal pain—Timolol—hypertension	1.33e-05	8.55e-05	CcSEcCtD
Zuclopenthixol—Body temperature increased—Timolol—hypertension	1.33e-05	8.55e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Losartan—hypertension	1.32e-05	8.53e-05	CcSEcCtD
Zuclopenthixol—Headache—Hydrochlorothiazide—hypertension	1.32e-05	8.51e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Furosemide—hypertension	1.32e-05	8.5e-05	CcSEcCtD
Zuclopenthixol—Rash—Furosemide—hypertension	1.31e-05	8.43e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Furosemide—hypertension	1.31e-05	8.42e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Betaxolol—hypertension	1.31e-05	8.41e-05	CcSEcCtD
Zuclopenthixol—Nausea—Captopril—hypertension	1.31e-05	8.41e-05	CcSEcCtD
Zuclopenthixol—Headache—Furosemide—hypertension	1.3e-05	8.37e-05	CcSEcCtD
Zuclopenthixol—Rash—Betaxolol—hypertension	1.3e-05	8.34e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Betaxolol—hypertension	1.29e-05	8.34e-05	CcSEcCtD
Zuclopenthixol—Headache—Betaxolol—hypertension	1.29e-05	8.29e-05	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Lisinopril—hypertension	1.28e-05	8.26e-05	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Lisinopril—hypertension	1.27e-05	8.2e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Losartan—hypertension	1.27e-05	8.2e-05	CcSEcCtD
Zuclopenthixol—Nausea—Perindopril—hypertension	1.27e-05	8.17e-05	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Ramipril—hypertension	1.26e-05	8.15e-05	CcSEcCtD
Zuclopenthixol—Nausea—Irbesartan—hypertension	1.26e-05	8.14e-05	CcSEcCtD
Zuclopenthixol—Rash—Losartan—hypertension	1.26e-05	8.13e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Losartan—hypertension	1.26e-05	8.12e-05	CcSEcCtD
Zuclopenthixol—Headache—Losartan—hypertension	1.25e-05	8.08e-05	CcSEcCtD
Zuclopenthixol—Nausea—Hydrochlorothiazide—hypertension	1.25e-05	8.07e-05	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Timolol—hypertension	1.24e-05	7.96e-05	CcSEcCtD
Zuclopenthixol—Nausea—Furosemide—hypertension	1.23e-05	7.94e-05	CcSEcCtD
Zuclopenthixol—Asthenia—Ramipril—hypertension	1.23e-05	7.93e-05	CcSEcCtD
Zuclopenthixol—Abdominal pain—Lisinopril—hypertension	1.23e-05	7.93e-05	CcSEcCtD
Zuclopenthixol—Body temperature increased—Lisinopril—hypertension	1.23e-05	7.93e-05	CcSEcCtD
Zuclopenthixol—Nausea—Betaxolol—hypertension	1.22e-05	7.86e-05	CcSEcCtD
Zuclopenthixol—Pruritus—Ramipril—hypertension	1.21e-05	7.82e-05	CcSEcCtD
Zuclopenthixol—Asthenia—Timolol—hypertension	1.2e-05	7.76e-05	CcSEcCtD
Zuclopenthixol—Nausea—Losartan—hypertension	1.19e-05	7.66e-05	CcSEcCtD
Zuclopenthixol—Pruritus—Timolol—hypertension	1.19e-05	7.65e-05	CcSEcCtD
Zuclopenthixol—Diarrhoea—Ramipril—hypertension	1.17e-05	7.57e-05	CcSEcCtD
Zuclopenthixol—Clozapine—HTR2A—hypertension	1.15e-05	0.00305	CrCbGaD
Zuclopenthixol—Diarrhoea—Timolol—hypertension	1.15e-05	7.4e-05	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Lisinopril—hypertension	1.15e-05	7.39e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Ramipril—hypertension	1.14e-05	7.31e-05	CcSEcCtD
Zuclopenthixol—Asthenia—Lisinopril—hypertension	1.12e-05	7.2e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Timolol—hypertension	1.11e-05	7.15e-05	CcSEcCtD
Zuclopenthixol—Pruritus—Lisinopril—hypertension	1.1e-05	7.1e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Ramipril—hypertension	1.09e-05	7.03e-05	CcSEcCtD
Zuclopenthixol—Chlorpromazine—HTR2A—hypertension	1.08e-05	0.00286	CrCbGaD
Zuclopenthixol—Rash—Ramipril—hypertension	1.08e-05	6.97e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Ramipril—hypertension	1.08e-05	6.97e-05	CcSEcCtD
Zuclopenthixol—Headache—Ramipril—hypertension	1.08e-05	6.93e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Timolol—hypertension	1.07e-05	6.87e-05	CcSEcCtD
Zuclopenthixol—Diarrhoea—Lisinopril—hypertension	1.07e-05	6.86e-05	CcSEcCtD
Zuclopenthixol—Rash—Timolol—hypertension	1.06e-05	6.82e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Timolol—hypertension	1.06e-05	6.81e-05	CcSEcCtD
Zuclopenthixol—Headache—Timolol—hypertension	1.05e-05	6.77e-05	CcSEcCtD
Zuclopenthixol—Dizziness—Lisinopril—hypertension	1.03e-05	6.63e-05	CcSEcCtD
Zuclopenthixol—Nausea—Ramipril—hypertension	1.02e-05	6.57e-05	CcSEcCtD
Zuclopenthixol—Nausea—Timolol—hypertension	9.97e-06	6.42e-05	CcSEcCtD
Zuclopenthixol—Vomiting—Lisinopril—hypertension	9.9e-06	6.38e-05	CcSEcCtD
Zuclopenthixol—Rash—Lisinopril—hypertension	9.82e-06	6.32e-05	CcSEcCtD
Zuclopenthixol—Dermatitis—Lisinopril—hypertension	9.81e-06	6.32e-05	CcSEcCtD
Zuclopenthixol—Headache—Lisinopril—hypertension	9.75e-06	6.28e-05	CcSEcCtD
Zuclopenthixol—Nausea—Lisinopril—hypertension	9.25e-06	5.96e-05	CcSEcCtD
Zuclopenthixol—Chlorpromazine—ALB—hypertension	7.42e-06	0.00196	CrCbGaD
Zuclopenthixol—HTR2A—Signaling Pathways—F2—hypertension	1.41e-06	1.62e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PRKCB—hypertension	1.41e-06	1.62e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—COMT—hypertension	1.41e-06	1.62e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—FN1—hypertension	1.41e-06	1.62e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—F2—hypertension	1.41e-06	1.62e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PRKCB—hypertension	1.41e-06	1.62e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MMP9—hypertension	1.41e-06	1.62e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NOTCH1—hypertension	1.4e-06	1.61e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CDKN1A—hypertension	1.4e-06	1.61e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—POMC—hypertension	1.4e-06	1.61e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PTEN—hypertension	1.4e-06	1.61e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HIF1A—hypertension	1.4e-06	1.6e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MTOR—hypertension	1.39e-06	1.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—INS—hypertension	1.39e-06	1.6e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GNB3—hypertension	1.39e-06	1.6e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARGC1A—hypertension	1.39e-06	1.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AGT—hypertension	1.39e-06	1.6e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—HMOX1—hypertension	1.39e-06	1.59e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—AKT1—hypertension	1.38e-06	1.59e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—FN1—hypertension	1.38e-06	1.59e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—F2—hypertension	1.38e-06	1.59e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PRKCB—hypertension	1.38e-06	1.59e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NOTCH1—hypertension	1.38e-06	1.59e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NOTCH1—hypertension	1.38e-06	1.58e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MAPK8—hypertension	1.37e-06	1.57e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CALM1—hypertension	1.37e-06	1.57e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CAT—hypertension	1.37e-06	1.57e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—AKT1—hypertension	1.37e-06	1.57e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—LEP—hypertension	1.36e-06	1.57e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOE—hypertension	1.36e-06	1.57e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GNAS—hypertension	1.35e-06	1.56e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NOTCH1—hypertension	1.35e-06	1.56e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CAV1—hypertension	1.35e-06	1.55e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOA1—hypertension	1.35e-06	1.55e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCL8—hypertension	1.34e-06	1.54e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—KDR—hypertension	1.33e-06	1.53e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—EP300—hypertension	1.33e-06	1.53e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOB—hypertension	1.33e-06	1.52e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—POMC—hypertension	1.31e-06	1.5e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—INS—hypertension	1.3e-06	1.49e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SRC—hypertension	1.3e-06	1.49e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—AKT1—hypertension	1.29e-06	1.49e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GSTM1—hypertension	1.29e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—POMC—hypertension	1.29e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PRKCB—hypertension	1.29e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—FN1—hypertension	1.29e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—F2—hypertension	1.29e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—POMC—hypertension	1.28e-06	1.48e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—INS—hypertension	1.28e-06	1.47e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL2—hypertension	1.28e-06	1.47e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—INS—hypertension	1.28e-06	1.47e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ALB—hypertension	1.28e-06	1.47e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—hypertension	1.27e-06	1.46e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—LPL—hypertension	1.27e-06	1.46e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—VEGFA—hypertension	1.26e-06	1.45e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—POMC—hypertension	1.26e-06	1.45e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL2—hypertension	1.26e-06	1.45e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF1—hypertension	1.26e-06	1.45e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NOTCH1—hypertension	1.26e-06	1.44e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AKT2—hypertension	1.26e-06	1.44e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL2—hypertension	1.26e-06	1.44e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—INS—hypertension	1.25e-06	1.44e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—EGFR—hypertension	1.25e-06	1.44e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ADCY5—hypertension	1.24e-06	1.43e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF1—hypertension	1.24e-06	1.42e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TP53—hypertension	1.24e-06	1.42e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AKT2—hypertension	1.24e-06	1.42e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GPX1—hypertension	1.24e-06	1.42e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF1—hypertension	1.23e-06	1.42e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AKT2—hypertension	1.23e-06	1.42e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL2—hypertension	1.23e-06	1.42e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—EGFR—hypertension	1.23e-06	1.42e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—EGFR—hypertension	1.23e-06	1.41e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PRKCA—hypertension	1.22e-06	1.41e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CYP1A1—hypertension	1.22e-06	1.41e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PIK3R1—hypertension	1.22e-06	1.4e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—NOS3—hypertension	1.22e-06	1.4e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF1—hypertension	1.21e-06	1.39e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MMP9—hypertension	1.21e-06	1.39e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AKT2—hypertension	1.21e-06	1.39e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CDKN1A—hypertension	1.21e-06	1.39e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—EGFR—hypertension	1.21e-06	1.39e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PTEN—hypertension	1.2e-06	1.38e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CD36—hypertension	1.2e-06	1.38e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SERPINE1—hypertension	1.19e-06	1.37e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MAPK8—hypertension	1.18e-06	1.35e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—AKT1—hypertension	1.18e-06	1.35e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SERPINE1—hypertension	1.18e-06	1.35e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SERPINE1—hypertension	1.17e-06	1.35e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—POMC—hypertension	1.17e-06	1.35e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—INS—hypertension	1.16e-06	1.34e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MYC—hypertension	1.16e-06	1.34e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TGFB1—hypertension	1.16e-06	1.33e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—FGF2—hypertension	1.16e-06	1.33e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RHOA—hypertension	1.15e-06	1.32e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SERPINE1—hypertension	1.15e-06	1.32e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—EP300—hypertension	1.15e-06	1.32e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL2—hypertension	1.15e-06	1.32e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MTHFR—hypertension	1.14e-06	1.31e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PIK3R1—hypertension	1.14e-06	1.31e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NOS3—hypertension	1.14e-06	1.31e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—FGF2—hypertension	1.14e-06	1.31e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—EGFR—hypertension	1.14e-06	1.31e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—FGF2—hypertension	1.14e-06	1.3e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RHOA—hypertension	1.13e-06	1.3e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—hypertension	1.13e-06	1.3e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RHOA—hypertension	1.13e-06	1.3e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF1—hypertension	1.13e-06	1.29e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AKT2—hypertension	1.13e-06	1.29e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NOS3—hypertension	1.12e-06	1.29e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PIK3R1—hypertension	1.12e-06	1.29e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—EGFR—hypertension	1.12e-06	1.29e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PIK3R1—hypertension	1.12e-06	1.29e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NOS3—hypertension	1.12e-06	1.29e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARA—hypertension	1.12e-06	1.29e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SRC—hypertension	1.12e-06	1.28e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTGS2—hypertension	1.12e-06	1.28e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—FGF2—hypertension	1.11e-06	1.28e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RHOA—hypertension	1.11e-06	1.28e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NOS3—hypertension	1.1e-06	1.26e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PIK3R1—hypertension	1.1e-06	1.26e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—VEGFA—hypertension	1.09e-06	1.25e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AGT—hypertension	1.08e-06	1.25e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RELA—hypertension	1.07e-06	1.23e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SERPINE1—hypertension	1.07e-06	1.23e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CALM1—hypertension	1.07e-06	1.22e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOE—hypertension	1.06e-06	1.22e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RELA—hypertension	1.06e-06	1.21e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RELA—hypertension	1.05e-06	1.21e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MTOR—hypertension	1.05e-06	1.21e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CAV1—hypertension	1.05e-06	1.21e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOA1—hypertension	1.05e-06	1.21e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—AKT1—hypertension	1.04e-06	1.2e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MTOR—hypertension	1.04e-06	1.19e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—FGF2—hypertension	1.04e-06	1.19e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RELA—hypertension	1.03e-06	1.19e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MTOR—hypertension	1.03e-06	1.19e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RHOA—hypertension	1.03e-06	1.19e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PIK3R1—hypertension	1.02e-06	1.17e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NOS3—hypertension	1.02e-06	1.17e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MTOR—hypertension	1.01e-06	1.17e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCL8—hypertension	1.01e-06	1.16e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MYC—hypertension	1e-06	1.15e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TGFB1—hypertension	9.99e-07	1.15e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCL8—hypertension	9.95e-07	1.14e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCL8—hypertension	9.93e-07	1.14e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—EGFR—hypertension	9.79e-07	1.13e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—AKT1—hypertension	9.77e-07	1.12e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCL8—hypertension	9.75e-07	1.12e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTEN—hypertension	9.74e-07	1.12e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—hypertension	9.62e-07	1.11e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—AKT1—hypertension	9.62e-07	1.1e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RELA—hypertension	9.61e-07	1.1e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AKT1—hypertension	9.59e-07	1.1e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TP53—hypertension	9.55e-07	1.1e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—hypertension	9.46e-07	1.09e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—hypertension	9.44e-07	1.09e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MTOR—hypertension	9.42e-07	1.08e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AKT1—hypertension	9.41e-07	1.08e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—EP300—hypertension	9.29e-07	1.07e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—hypertension	9.27e-07	1.06e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARG—hypertension	9.25e-07	1.06e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MMP9—hypertension	9.15e-07	1.05e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—POMC—hypertension	9.12e-07	1.05e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CDKN1A—hypertension	9.12e-07	1.05e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PTEN—hypertension	9.1e-07	1.05e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—INS—hypertension	9.07e-07	1.04e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCL8—hypertension	9.06e-07	1.04e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MMP9—hypertension	9e-07	1.03e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MMP9—hypertension	8.98e-07	1.03e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CDKN1A—hypertension	8.97e-07	1.03e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CDKN1A—hypertension	8.95e-07	1.03e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PTEN—hypertension	8.95e-07	1.03e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PTEN—hypertension	8.93e-07	1.03e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MAPK8—hypertension	8.9e-07	1.02e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AKT1—hypertension	8.87e-07	1.02e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MMP9—hypertension	8.82e-07	1.01e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CDKN1A—hypertension	8.78e-07	1.01e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PTEN—hypertension	8.76e-07	1.01e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MAPK8—hypertension	8.76e-07	1.01e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AKT1—hypertension	8.75e-07	1.01e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—hypertension	8.74e-07	1e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MAPK8—hypertension	8.74e-07	1e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AKT1—hypertension	8.73e-07	1e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AKT1—hypertension	8.71e-07	1e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—EP300—hypertension	8.67e-07	9.97e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—hypertension	8.61e-07	9.89e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MAPK8—hypertension	8.57e-07	9.85e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AKT1—hypertension	8.55e-07	9.82e-06	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—EP300—hypertension	8.54e-07	9.81e-06	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—EP300—hypertension	8.52e-07	9.79e-06	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SRC—hypertension	8.44e-07	9.69e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—EP300—hypertension	8.36e-07	9.6e-06	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ALB—hypertension	8.32e-07	9.56e-06	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SRC—hypertension	8.3e-07	9.54e-06	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SRC—hypertension	8.28e-07	9.52e-06	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TP53—hypertension	8.22e-07	9.45e-06	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—VEGFA—hypertension	8.22e-07	9.44e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MMP9—hypertension	8.19e-07	9.41e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CDKN1A—hypertension	8.16e-07	9.38e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PTEN—hypertension	8.14e-07	9.36e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SRC—hypertension	8.13e-07	9.34e-06	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—VEGFA—hypertension	8.08e-07	9.29e-06	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—VEGFA—hypertension	8.07e-07	9.27e-06	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AKT1—hypertension	8.07e-07	9.27e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MAPK8—hypertension	7.97e-07	9.15e-06	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PIK3R1—hypertension	7.96e-07	9.14e-06	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—NOS3—hypertension	7.96e-07	9.14e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AKT1—hypertension	7.94e-07	9.13e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—VEGFA—hypertension	7.92e-07	9.1e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—EP300—hypertension	7.77e-07	8.92e-06	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MYC—hypertension	7.56e-07	8.69e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SRC—hypertension	7.55e-07	8.68e-06	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TGFB1—hypertension	7.54e-07	8.66e-06	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—hypertension	7.53e-07	8.65e-06	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MYC—hypertension	7.44e-07	8.55e-06	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MYC—hypertension	7.42e-07	8.53e-06	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TGFB1—hypertension	7.42e-07	8.53e-06	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TGFB1—hypertension	7.4e-07	8.51e-06	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—EGFR—hypertension	7.39e-07	8.5e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—VEGFA—hypertension	7.35e-07	8.45e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MYC—hypertension	7.28e-07	8.37e-06	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTGS2—hypertension	7.28e-07	8.36e-06	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—EGFR—hypertension	7.27e-07	8.36e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TGFB1—hypertension	7.27e-07	8.35e-06	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—EGFR—hypertension	7.26e-07	8.34e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—EGFR—hypertension	7.12e-07	8.19e-06	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AKT1—hypertension	6.94e-07	7.98e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MYC—hypertension	6.77e-07	7.78e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TGFB1—hypertension	6.75e-07	7.76e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—EGFR—hypertension	6.62e-07	7.61e-06	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTEN—hypertension	6.35e-07	7.29e-06	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TP53—hypertension	6.21e-07	7.13e-06	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TP53—hypertension	6.11e-07	7.02e-06	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TP53—hypertension	6.1e-07	7e-06	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—EP300—hypertension	6.05e-07	6.95e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TP53—hypertension	5.98e-07	6.87e-06	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—hypertension	5.68e-07	6.53e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—AKT1—hypertension	5.61e-07	6.45e-06	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—hypertension	5.59e-07	6.42e-06	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—hypertension	5.58e-07	6.41e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TP53—hypertension	5.56e-07	6.39e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—hypertension	5.47e-07	6.29e-06	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AKT1—hypertension	5.24e-07	6.02e-06	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AKT1—hypertension	5.16e-07	5.93e-06	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AKT1—hypertension	5.15e-07	5.91e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—hypertension	5.09e-07	5.84e-06	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AKT1—hypertension	5.05e-07	5.8e-06	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AKT1—hypertension	4.69e-07	5.39e-06	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AKT1—hypertension	3.66e-07	4.2e-06	CbGpPWpGaD
